Skip to main content
Fig. 1 | Orphanet Journal of Rare Diseases

Fig. 1

From: Repurposing propranolol as a drug for the treatment of retinal haemangioblastomas in von Hippel-Lindau disease

Fig. 1

a Evolution of Patient 1 included in the clinical trial. The graphic is based on the notes written by the different ophthalmologists in his clinical history, and represents the evolution before and during the clinical trial. The dotted lines denote the time of propranolol administration in the clinical trial. b The patient had retinal exudation that decreased as treatment progressed, as demonstrated at three different time points during the clinical trial

Back to article page

Orphanet Journal of Rare Diseases

ISSN: 1750-1172